Paper33477288
The Match between Molecular Subtypes, Histology and Microenvironment of Pancreatic Cancer and Its Relevance for Chemoresistance.
Martinez-Useros J and 2 others. Cancers (Basel), 2021. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. The Match between Molecular Subtypes, Histology and Microenvironment of Pancreatic Cancer and Its Relevance for Chemoresistance. Papers, record 33477288. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33477288
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Match between Molecular Subtypes, Histology and Microenvironment of Pancreatic Cancer and Its Relevance for Chemoresistance.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References118
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32127405 | Regulatory T Cells Keep Pancreatic Cancer at Bay. | Cancer Discov | 2020 | https://conductscience.org/library/papers/32127405 | PubMed |
| 2 | 25845856 | Pancreatic cancer: The microenvironment needs attention too! | Pancreatology | 2015 | https://conductscience.org/library/papers/25845856 | PubMed |
| 3 | 25584002 | Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/25584002 | PubMed |
| 4 | 31281314 | SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities. | Front Immunol | 2019 | https://conductscience.org/library/papers/31281314 | PubMed |
| 5 | 22777597 | Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma. | Int J Cancer | 2013 | https://conductscience.org/library/papers/22777597 | PubMed |
| 6 | 18273037 | Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. | Nat Rev Cancer | 2008 | https://conductscience.org/library/papers/18273037 | PubMed |
| 7 | 14707728 | Tumor-stroma interaction of human pancreatic cancer: acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins. | Pancreas | 2004 | https://conductscience.org/library/papers/14707728 | PubMed |
| 8 | 25743105 | Whole exome sequencing reveals recurrent mutations in BRCA2 and FAT genes in acinar cell carcinomas of the pancreas. | Sci Rep | 2015 | https://conductscience.org/library/papers/25743105 | PubMed |
| 9 | 32823814 | Mechanisms of T-Cell Exhaustion in Pancreatic Cancer. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32823814 | PubMed |
| 10 | 32917658 | Lactate-Modulated Immunosuppression of Myeloid-Derived Suppressor Cells Contributes to the Radioresistance of Pancreatic Cancer. | Cancer Immunol Res | 2020 | https://conductscience.org/library/papers/32917658 | PubMed |
| 11 | 30315083 | Improved Detection of Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasms. | Oncologist | 2018 | https://conductscience.org/library/papers/30315083 | PubMed |
| 12 | 23108411 | MUC1 enhances hypoxia-driven angiogenesis through the regulation of multiple proangiogenic factors. | Oncogene | 2013 | https://conductscience.org/library/papers/23108411 | PubMed |
| 13 | 32516943 | Targeting the CBP/β-Catenin Interaction to Suppress Activation of Cancer-Promoting Pancreatic Stellate Cells. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32516943 | PubMed |
| 14 | 19690057 | Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Ann Oncol | 2010 | https://conductscience.org/library/papers/19690057 | PubMed |
| 15 | 26808421 | Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology. | PLoS One | 2016 | https://conductscience.org/library/papers/26808421 | PubMed |
| 16 | 27322081 | Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer. | Oncotarget | 2016 | https://conductscience.org/library/papers/27322081 | PubMed |
| 17 | 23671746 | Imaging of pancreatic ductal adenocarcinoma: State of the art. | World J Radiol | 2013 | https://conductscience.org/library/papers/23671746 | PubMed |
| 18 | 25270260 | Emerging from the shade of p53 mutants: N-terminally truncated variants of the p53 family in EMT signaling and cancer progression. | Sci Signal | 2014 | https://conductscience.org/library/papers/25270260 | PubMed |
| 19 | 25063451 | The nuclear hormone receptor family member NR5A2 controls aspects of multipotent progenitor cell formation and acinar differentiation during pancreatic organogenesis. | Development | 2014 | https://conductscience.org/library/papers/25063451 | PubMed |
| 20 | 24277834 | Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/24277834 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42755980 | Targeting pancreatic cancer with natural compounds: molecular mechanisms, preclinical evidence, clinical perspectives, and limitations. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42755980 | PubMed |
| 40399795 | Lactate-associated gene MCU promotes the proliferation, migration, and invasion of pancreatic ductal adenocarcinoma. | BMC Cancer | 2025 | https://conductscience.org/library/papers/40399795 | PubMed |
| 39992560 | Trends in the Global Incidence of Pancreatic Cancer and a Brief Review of its Histologic and Molecular Subtypes. | J Gastrointest Cancer | 2025 | https://conductscience.org/library/papers/39992560 | PubMed |
| 39987295 | Spatial recognition and semi-quantification of epigenetic events in pancreatic cancer subtypes with multiplexed molecular imaging and machine learning. | Sci Rep | 2025 | https://conductscience.org/library/papers/39987295 | PubMed |
| 39594547 | Glutathione Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39594547 | PubMed |
| 37834426 | Iron-Dependent Cell Death: A New Treatment Approach against Pancreatic Ductal Adenocarcinoma. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37834426 | PubMed |
| 37296886 | PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37296886 | PubMed |
| 37089813 | Deletion of the mRNA stability factor ELAVL1 (HuR) in pancreatic cancer cells disrupts the tumor microenvironment integrity. | NAR Cancer | 2023 | https://conductscience.org/library/papers/37089813 | PubMed |
| 36949200 | RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer. | Nature | 2023 | https://conductscience.org/library/papers/36949200 | PubMed |
| 36761421 | HROP68: A rare case of medullary pancreatic cancer-characterization and chemosensitivity of the first patient-derived cell line. | Front Oncol | 2022 | https://conductscience.org/library/papers/36761421 | PubMed |
| 36555927 | A Novel PiRNA Enhances CA19-9 Sensitivity for Pancreatic Cancer Identification by Liquid Biopsy. | J Clin Med | 2022 | https://conductscience.org/library/papers/36555927 | PubMed |
| 36238134 | Survivin Splice Variant 2β Enhances Pancreatic Ductal Adenocarcinoma Resistance to Gemcitabine. | Onco Targets Ther | 2022 | https://conductscience.org/library/papers/36238134 | PubMed |
| 36092937 | Expression of lactate-related signatures correlates with immunosuppressive microenvironment and prognostic prediction in ewing sarcoma. | Front Genet | 2022 | https://conductscience.org/library/papers/36092937 | PubMed |
| 36010260 | Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/36010260 | PubMed |
| 36006427 | Correlation of transcriptional subtypes with a validated CT radiomics score in resectable pancreatic ductal adenocarcinoma. | Eur Radiol | 2022 | https://conductscience.org/library/papers/36006427 | PubMed |
| 35565450 | Current Pathology Model of Pancreatic Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35565450 | PubMed |
| 34707986 | Application of Mass Spectrometry in Pancreatic Cancer Translational Research. | Front Oncol | 2021 | https://conductscience.org/library/papers/34707986 | PubMed |
| 34685604 | Nuclear Dynamics and Chromatin Structure: Implications for Pancreatic Cancer. | Cells | 2021 | https://conductscience.org/library/papers/34685604 | PubMed |
| 34511884 | Integrating Network Pharmacology and Experimental Verification to Explore the Mechanism of Effect of Zuojin Pills in Pancreatic Cancer Treatment. | Drug Des Devel Ther | 2021 | https://conductscience.org/library/papers/34511884 | PubMed |
| 34447748 | Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction Model. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34447748 | PubMed |
Genes220
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33477288
GET https://conductscience.org/api/papers/v1/33477288/references?page=2